Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Conditions
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
Interventions
- DRUG: Cobimetinib
- DRUG: Enasidenib Mesylate
Sponsor
City of Hope Medical Center
Collaborators